Avadel Pharmaceuticals (AVDL) Net Margin (2016 - 2020)
Historic Net Margin for Avadel Pharmaceuticals (AVDL) over the last 11 years, with Q2 2020 value amounting to 305.96%.
- Avadel Pharmaceuticals' Net Margin rose 3549800.0% to 305.96% in Q2 2020 from the same period last year, while for Mar 2021 it was 7.85%, marking a year-over-year increase of 1412300.0%. This contributed to the annual value of 28.3% for FY2020, which is 1001000.0% up from last year.
- As of Q2 2020, Avadel Pharmaceuticals' Net Margin stood at 305.96%, which was up 3549800.0% from 84.74% recorded in Q1 2020.
- Avadel Pharmaceuticals' Net Margin's 5-year high stood at 305.96% during Q2 2020, with a 5-year trough of 414.21% in Q4 2019.
- For the 5-year period, Avadel Pharmaceuticals' Net Margin averaged around 44.14%, with its median value being 42.89% (2018).
- Per our database at Business Quant, Avadel Pharmaceuticals' Net Margin tumbled by -2815300bps in 2018 and then soared by 3549800bps in 2020.
- Avadel Pharmaceuticals' Net Margin (Quarter) stood at 10.99% in 2016, then plummeted by -316bps to 23.73% in 2017, then crashed by -1187bps to 305.25% in 2018, then plummeted by -36bps to 414.21% in 2019, then skyrocketed by 174bps to 305.96% in 2020.
- Its last three reported values are 305.96% in Q2 2020, 84.74% for Q1 2020, and 414.21% during Q4 2019.